Infectious diseases

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.

Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bio-terrorism.

A screen of 2000 synthetic compounds has uncovered a novel agent against antiviral resistant influenza.

A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)

A vaccine using mRNA demonstrates potential for broad influenza protection.

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Sitting Down With… Carolyn Bertozzi, Anne T. and Robert M. Bass Professor of Chemistry, and Professor (by courtesy) of Chemical & Systems Biology and Radiology,Stanford University, USA.